| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 06/06/2024 | 13:49 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ICCC | ImmuCell Corporation |
| 05/06/2024 | 22:05 | GlobeNewswire Inc. | ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain® | NASDAQ:ICCC | ImmuCell Corporation |
| 04/06/2024 | 22:05 | GlobeNewswire Inc. | ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders | NASDAQ:ICCC | ImmuCell Corporation |
| 22/05/2024 | 22:50 | Edgar (US Regulatory) | Form SCHEDULE 13D - General statement of acquisition of beneficial ownership | NASDAQ:ICCC | ImmuCell Corporation |
| 14/05/2024 | 22:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ICCC | ImmuCell Corporation |
| 14/05/2024 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 | NASDAQ:ICCC | ImmuCell Corporation |
| 08/05/2024 | 19:00 | GlobeNewswire Inc. | ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 | NASDAQ:ICCC | ImmuCell Corporation |
| 09/04/2024 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 | NASDAQ:ICCC | ImmuCell Corporation |
| 27/02/2024 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 16/02/2024 | 15:30 | GlobeNewswire Inc. | ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 08/01/2024 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 13/11/2023 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 07/11/2023 | 18:15 | GlobeNewswire Inc. | ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 05/10/2023 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 06/09/2023 | 18:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ICCC | ImmuCell Corporation |
| 29/08/2023 | 14:00 | GlobeNewswire Inc. | ImmuCell Announces Submission of CMC Technical Section to the FDA | NASDAQ:ICCC | ImmuCell Corporation |
| 10/08/2023 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 07/08/2023 | 18:00 | GlobeNewswire Inc. | ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 13/07/2023 | 20:28 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:ICCC | ImmuCell Corporation |
| 11/07/2023 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 29/06/2023 | 19:03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ICCC | ImmuCell Corporation |
| 28/06/2023 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Change in Timing of Anticipated FDA Submission | NASDAQ:ICCC | ImmuCell Corporation |
| 21/06/2023 | 22:05 | GlobeNewswire Inc. | ImmuCell Appoints Bryan K. Gathagan to Board of Directors | NASDAQ:ICCC | ImmuCell Corporation |
| 15/06/2023 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility | NASDAQ:ICCC | ImmuCell Corporation |
| 11/05/2023 | 22:07 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ICCC | ImmuCell Corporation |
| 11/05/2023 | 22:05 | GlobeNewswire Inc. | ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 04/05/2023 | 12:30 | GlobeNewswire Inc. | ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023 | NASDAQ:ICCC | ImmuCell Corporation |
| 28/04/2023 | 16:18 | Edgar (US Regulatory) | Annual Report to Security Holders (ars) | NASDAQ:ICCC | ImmuCell Corporation |
| 28/04/2023 | 16:14 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ICCC | ImmuCell Corporation |
| 18/04/2023 | 23:11 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:ICCC | ImmuCell Corporation |